產(chǎn)品名稱 | FITC標(biāo)記的GTP酶激活蛋白ASAP3抗體 |
英文名稱 | Anti-ASAP3/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-ASAP3/FITC
中文名稱 FITC標(biāo)記的GTP酶激活蛋白ASAP3抗體
規(guī)格:100ul
說(shuō)明書(shū) 100ul
研究領(lǐng)域腫瘤 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞粘附分子
抗體來(lái)源Rabbit
克隆類型Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量99kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated synthetic peptide derived from human ASAP3
亞 型IgG
純化方法affinity purified by Protein A
儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 1; ACAP4; Arf GAP with SH3 domain; Arf GAP with SH3 domain, ANK repeat and PH domain containing protein 3; ARF6 GTPase activating protein; ArfGAP with SH3 domain, ankyrin repeat and PH domain; Centaurin, beta 6; CENTB6; DDEFL1; Development and differentiation enhancing factor like 1; Up regulated in liver cancer 1 (UPLC1); UPLC1.
